MedPath

Administration of ketamine into spinal Anaesthesia to prevent post amputation perception of pain in a limb that is no longer there.

Phase 1
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/10/058385
Lead Sponsor
Kathija Begam A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient undergoing elective lower extremity amputation under Subarachnoid Block

2. Age between 18-65 years old

3. American Society of Anaesthesiologists (ASA) I & II

Exclusion Criteria

1.Patients known allergic to either of the study drugs [Bupivacaine or Ketamine].

2.Patients with neuro-behavioural changes, severe diabetic /autonomic neuropathy.

3.Patients on long term analgesic medications and contraindicated for subarachnoid block.

4. Patients who failed follow ups for pain evaluation.

5. Patients who undergo further amputation during the follow up period are excluded from the further analysis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post operatively patient is developing the perception of pain or discomfort in a limb that is no longer there.Timepoint: from 6 hours to 6 months postoperatively
Secondary Outcome Measures
NameTimeMethod
To assess the incidence and severity of post amputation phantom limb pain.Timepoint: from 6 hours to 6 months postoperatively
© Copyright 2025. All Rights Reserved by MedPath